acellular nerve allograft-arwx (avance nerve graft)
acellular nerve allograft-arwx is an FDA-licensed reference biologic from Axogen Corporation. Reference exclusivity, biosimilar lineage, and published patents from official FDA Purple Book records.
0
Biosimilars
0
Interchangeables
0
Listed patents
2025
Reference approved
Reference product
avance nerve graft acellular nerve allograft-arwx
Axogen Corporation
- Approved
- Dec 03, 2025
- Marketing
- Rx
- Center
- CBER
- Patents
- None listed
Exclusivity & patent cliffs
Approval, exclusivity, and published-patent expiration dates for acellular nerve allograft-arwx, in chronological order.
Reference approval
Approval date of the reference acellular nerve allograft-arwx product.
6 mo ago
Frequently asked questions
Are there biosimilars approved for acellular nerve allograft-arwx (avance nerve graft)?
No 351(k) biosimilars or interchangeable biosimilars referencing acellular nerve allograft-arwx are listed in the FDA Purple Book yet.
Explore the full FDA Purple Book
Search every FDA-licensed biologic, biosimilar, and interchangeable with exclusivity timelines and patent records.